Nelarabine
novartis
['leusm']
improved outcomes in graall 2014 vs. 2005 with age adapted dose intensity reduciton and restriction of allo hsct in cr1 to poor mrd responders #ash22 #leusm 
Associate Professor @UANL Monterrey, Mexico. Interested in HSCT, acute leukemia in LMIC. ASTCT. LABMT. ASH. AMEH. SMTT. #bmtsm #leusm #mmsm #lymsm #GlobalBMT